About the Macular Dystrophy Session
Macular dystrophy refers to a cluster of genetic eye disorders impacting the macula, the central portion of the retina essential for sharp vision. Conditions like Stargardt disease and Best disease fall under this umbrella, progressively deteriorating the macula. Symptoms often surface during childhood or adolescence, including distorted vision, difficulty in low light, and impaired color perception. While a cure remains elusive, various management approaches exist, such as utilizing low-vision aids, undergoing genetic counseling, and exploring experimental treatments like gene therapy to mitigate progression and alleviate symptoms. Regular consultations with an ophthalmologist are vital to monitor changes and optimize strategies for maintaining visual function.
Topics Covered in Macular Dystrophy
Stargardt Disease
Best Vitelliform Dystrophy
Pattern Dystrophy
Fundus Autofluorescence
Genetic Testing & Counseling
Low Vision Aids
Related Scientific Sessions at IOC 2027
Why Attend the Macular Dystrophy Conference 2027
Earn CPD Credit
Sessions are CPD-accredited by The CPD Group (UK) — one CPD credit for every hour of attendance.
Present Your Research
Oral and poster slots for original Macular Dystrophy work, reviewed by the scientific committee.
Network Globally
Meet ophthalmologists, vision scientists, and eye-care clinicians from around the world across three days.
Publish & Get Indexed
Accepted abstracts are compiled into the conference proceedings and indexed in Scopus and Web of Science.
Learn from Keynotes
Plenary lectures from leading voices shaping Macular Dystrophy research and practice.
Hybrid Flexibility
Attend in person in Singapore or join virtually — same programme, same certificate.
Join IOC 2027 for the Macular Dystrophy track
Oral and poster slots for your work — in person in Singapore or online. Not presenting? Attend as a delegate to learn from the field.
Macular Dystrophy Conference 2027 — FAQs
What is the Macular Dystrophy track at IOC 2027?
The Macular Dystrophy track is a dedicated stream within IOC 2027 covering the latest research, clinical innovation, and best practice in Macular Dystrophy. It brings together researchers, educators, and practitioners for oral presentations, posters, and discussion.
Who should attend the Macular Dystrophy sessions?
Ophthalmologists, optometrists, vision scientists, educators, doctoral students, and trainees with an interest in Macular Dystrophy are all welcome — whether presenting or attending.
Can I present my research in the Macular Dystrophy track?
Yes. Submit an abstract for oral or poster presentation. All submissions are peer-reviewed by the scientific committee; accepted abstracts appear in the indexed proceedings.
Is virtual attendance available for Macular Dystrophy sessions?
Yes. IOC 2027 is a hybrid conference — attend the Macular Dystrophy track in person in Singapore or join live online, with on-demand access afterward.
Join the IOC 2027 delegation
Singapore · March 15–17, 2027· Hybrid · in-person & virtual
Attend without presenting.